Notice of Closed Meeting, 50377-50378 [2018-21700]
Download as PDF
<![CDATA[
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 194 / Friday, October 5, 2018 / Notices
on all matters regarding internal
business service operations; (5)
maintains internal controls; (6)
coordinates and manages operationally
focused project teams; (7) provides
leadership and strategic support in the
determination of long-term operational
needs; (8) provides collaboration and
centralized consolidation of Office
reporting requirements; (9) provides
strategic planning and coordination of
OCIO transformation projects and
initiatives; and (10) manages and
implements special projects sponsored
by OCIO leadership.
Policy, Performance and
Communications Activity (CAJR162). (1)
Provides leadership, oversight, and
guidance for OCIO Enterprise Risk
Management; (2) identifies systemic
operational risks and issues and
communicates them to OCIO leadership
for consideration, mitigation and issue
resolution; (3) provides leadership,
coordination, and collaboration on
OCIO issues management and triaging,
and ensures the process of ongoing
issues identification, management and
resolution; (4) establishes OCIO
business performance metrics and
coordinates reviews to ascertain status
on meeting the metrics; (5) conducts
business analytics and reporting on
performance data collected from other
OCIO offices and sections; (6) provides
reporting for annual planning meetings,
annual reports, data calls, end-of-year
coordination, and ad-hoc requests; (7)
leads OCIO performance management,
including the development of strategic
plans, performance metrics, dashboards,
and Quarterly Program Review
materials; (8) manages and coordinates
the development of organizational and
CDC-wide information technology
policies to support CDC’s public health
science and programs; (9) manages and
responds to Congressional inquiries and
media requests as it relates to support of
CDC’s information technology policies;
(10) serves as the point of contact for the
policy analysis, technical review and
final clearance of executive
correspondence and policy documents
that require approval from the Chief
Information Officer, OCIO Leadership
Team, or officials; (11) provides
coordination and oversight for internal
and external OCIO communications;
(12) provides communications support
for executive presentations, messages,
and meetings; (13) ensures accurate and
consistent information dissemination,
including Freedom Of Information Act
requests and Executive Secretariat
controlled correspondence; (14) ensures
consistent application of CDC
correspondence standards and styles;
VerDate Sep<11>2014
17:11 Oct 04, 2018
Jkt 247001
and (15) provides leadership, technical
assistance, and consultation in
establishing best practices in internal
and external business communication
and implements external
communication strategies to promote
and protect OCIO and the agency’s
brand (e.g. employee communications,
intranet, internet and other
communication platforms).
Management Services Activity
(CAJR163). (1) Provides budgetary
information for business decisionmaking support surrounding
information technology investments in
support of the agency’s mission and
goals; (2) provides OCIO spend plan
validation, remediation, and analysis;
(3) prepares annual OCIO budget
formulation and budget justifications;
(4) ensures budget plans and changes
are in compliance with decisions and
agency direction; (5) plans, develops,
manages, and conducts oversight of
CDC’s information services contracts; (6)
coordinates and facilitates OCIO
contracts use including requirements
development, specifications,
performance needs, quality assurance
and service delivery, and contract
administration; (7) provides guidance
and assistance to programs on the
various aspects of the contracts to meet
their requirements; (8) coordinates and
manages annual contract forecasting
activities; (9) participates with senior
management in program planning,
policy determinations, evaluations, and
decisions concerning escalation points
for acquisitions and financial
management; (10) conducts policy
analysis, tracking, review and clearance
as it relates to acquisitions and financial
management to support CDC’s public
health science and programs; (11)
provides workforce and human capital
management oversight and direction for
all OCIO components including
employee relations; (12) gathers and
analyzes information concerning OCIO
workforce challenges and/or
opportunities for leadership awareness,
strategic planning, and operational
improvement; (13) collects and analyzes
data from employee viewpoint surveys
and other sources to inform OCIO
leadership and future initiatives; and
(14) provides and oversees the delivery
of OCIO-wide administrative
management and support services in the
areas of fiscal management, personnel,
travel, records management, internal
controls, and other administrative
services.
Enterprise Data Office (CARG). (1)
Develops, promotes, implements, and
evaluates data science approaches for
improved research of large and complex
data sets; (2) maintains and leverages
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
50377
data acquired from multiple sources; (3)
develops and implements solutions,
often with partners and collaborators, to
strengthen information systems and
reporting; (4) develops and implements
computer-based decision support tools
and mobile applications that help to
inform better decision-making; and (5)
collaborates with other CDC programs to
develop and promote informatics
solutions for improving data
management, practice, and
preparedness; and (6) promotes a
multidisciplinary approach (which
includes statistics, analytics, data
management, informatics, and
evaluation sciences) to assure that the
CDC programs, information systems,
and data serve public health program
objectives.
Delete in their entirety the titles and
functional statements for the Enterprise
Information Technology Portfolio Office
(CAJR12), Acquisition Program
Management Office (CAJR14), and the
Management Analysis and Services
Office (CAJRC).
Delete in its entirety the title and
functional statement for Informatics
Innovation Unit (CPNC12), Office of the
Director (CPN1), Center for Surveillance,
Epidemiology, and Laboratory Services
(CPN).
This reorganization was approved by the
Director, CDC.
Robert Redfield,
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–21670 Filed 10–4–18; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
E:\FR\FM\05OCN1.SGM
05OCN1
50378
Federal Register / Vol. 83, No. 194 / Friday, October 5, 2018 / Notices
constitute a clearly unwarranted
invasion of privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 15–352, Occupational Safety and
Health Training Projects.
Date: December 05, 2018.
Time: 1:00 p.m.–5:00 p.m. EST.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, CDC, 1095 Willowdale Road,
Morgantown, West Virginia, 26505,
(304) 285–5951; mgoldcamp@cdc.gov.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–21700 Filed 10–4–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). This meeting is open to the
public, is limited only by room seating
available, (120). The public is also
welcome to listen to the meeting via
teleconference at 800–857–9838,
passcode: 5325685; 100 teleconference
lines are available.
DATES: The meeting will be held on
November 15, 2018, 9:00 a.m. to 5:00
p.m., EST, and November 16, 2018, 9:00
a.m. to 12:00 p.m., EST.
ADDRESSES: Centers for Disease Control
and Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE, Atlanta, Georgia
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:11 Oct 04, 2018
Jkt 247001
30329–4027 and teleconference at 800–
857–9838, passcode: 5325685.
FOR FURTHER INFORMATION CONTACT: Erin
Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, 1600 Clifton Road NE, Mailstop
A–07, Atlanta, Georgia 30329,
Telephone (404) 639–4045. Email:
hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION: Time will
be available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt of
written public comment is November 1,
2018. All requests must contain the
name, address, and organizational
affiliation of the speaker, as well as the
topic being addressed. Written
comments should not exceed one singlespaced typed page in length and
delivered in 3 minutes or less. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated, following the last call
for comments. Written comments
received in advance of the meeting will
be included in the official record of the
meeting. Registration is required to
attend in person or on the phone.
Interested parties must be processed in
accordance with established federal
policies and procedures and may
register at www.cdc.gov/hicpac.
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Health and Human Services, regarding
(1) the practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
The Healthcare Personnel Guideline
Workgroup; the National Healthcare
Safety Network (NHSN) Workgroup; the
Neonatal Intensive Care Unit (NICU)
Guideline Workgroup; and the Products
and Practices Workgroup. Agenda items
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
are subject to change as priorities
dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–21701 Filed 10–4–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—CK19–001,
Identification, Surveillance, and Control of
Vector-Borne and Zoonotic Infectious
Diseases in Uganda.
Date: January 3, 2019.
Time: 12:00 p.m.–1:30 p.m., (EST).
Place: Teleconference, Centers for Disease
Control and Prevention, Room 1080, 8
Corporate Square Blvd., Atlanta, GA 30329.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Gregory
Anderson, M.S., M.P.H., Scientific Review
Officer, CDC, 1600 Clifton Road NE, Mailstop
E60, Atlanta, Georgia 30333, (404) 718–8833,
gca5@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 83, Number 194 (Friday, October 5, 2018)]
[Notices]
[Pages 50377-50378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21700]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Chief Operating
Officer, CDC, pursuant to Public Law 92-463. The grant applications and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would
[[Page 50378]]
constitute a clearly unwarranted invasion of privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)--PAR 15-352, Occupational Safety
and Health Training Projects.
Date: December 05, 2018.
Time: 1:00 p.m.-5:00 p.m. EST.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Michael Goldcamp, Ph.D.,
Scientific Review Officer, Office of Extramural Programs, CDC, 1095
Willowdale Road, Morgantown, West Virginia, 26505, (304) 285-5951;
[email protected].
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-21700 Filed 10-4-18; 8:45 am]
BILLING CODE 4163-18-P
